p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target

CONCLUSION: Our research may provide a novel potential target for TNBC.PMID:36352176 | DOI:10.1007/s11033-022-08047-z

Source: Mol Biol Cell - November 9, 2022 Category: Molecular Biology Authors: Siyu Deng Mengna Wang Chenglong Wang Yan Zeng Xue Qin Yiwen Tan Bing Liang Youde Cao Source Type: research